Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients

Gonzalo Laje, Níall Lally, Daniel Mathews, Nancy Brutsche, Anat Chemerinski, Nirmala Akula, Benjamin Kelmendi, Arthur Simen, Francis J. McMahon, Gerard Sanacora, Carlos Zarate

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e27-e28
JournalBiological psychiatry
Volume72
Issue number11
DOIs
StatePublished - Dec 1 2012

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Laje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., & Zarate, C. (2012). Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. Biological psychiatry, 72(11), e27-e28. https://doi.org/10.1016/j.biopsych.2012.05.031